Column Capital Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.63K Hold
58
﹤0.01% 702
2023
Q2
$2.14K Hold
58
﹤0.01% 706
2023
Q1
$1.74K Hold
58
﹤0.01% 732
2022
Q4
$1.78K Hold
58
﹤0.01% 710
2022
Q3
$1K Hold
58
﹤0.01% 668
2022
Q2
$2K Hold
58
﹤0.01% 627
2022
Q1
$2K Sell
58
-4
-6% -$125 ﹤0.01% 642
2021
Q4
$2K Sell
62
-2
-3% -$62 ﹤0.01% 646
2021
Q3
$2K Sell
64
-11
-15% -$356 ﹤0.01% 615
2021
Q2
$3K Hold
75
﹤0.01% 583
2021
Q1
$2K Hold
75
﹤0.01% 602
2020
Q4
$2K Sell
75
-11
-13% -$262 ﹤0.01% 592
2020
Q3
$2K Sell
86
-16
-16% -$309 ﹤0.01% 584
2020
Q2
$1K Hold
102
﹤0.01% 716
2020
Q1
$1K Hold
102
﹤0.01% 600
2019
Q4
$1K Buy
+102
New +$1.69K ﹤0.01% 638

Other funds holding CC

Column Capital Advisors's CC Position: Q3 2023 in Review

Column Capital Advisors held its Chemours (CC) position steady in Q3 2023 at 58 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Column Capital Advisors first reported a position in CC in Q4 2019 and has held it in 16 quarters since. The position peaked at $3K in Q2 2021. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Column Capital Advisors held 58 shares of Chemours worth $1.63K as of Q3 2023.
  • Column Capital Advisors left its Chemours share count unchanged in Q3 2023.
  • Chemours made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #702 holding.
  • Column Capital Advisors first reported a position in Chemours in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Chemours position peaked at $3K in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.